2010 annual financial data
Ligand Pharmaceuticals 2010 Revenue growth
Direct answer
Revenue growth was -39.55%.
Operating income was -29,304,000 USD and net income was -12,515,000 USD.
Operating cash flow was -27,067,000 USD.
Get free Ligand Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 23,538,000 USD
- Operating income
- -29,304,000 USD
- Net income
- -12,515,000 USD
- Operating cash flow
- -27,067,000 USD